NU-1001-41

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNU-1001-41
Drug Alias Nameanti-phospho-AKT monoclonal antibodies (Nuclea Biotechnologies)NU-1001-41
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProto-oncogene proteins c-akt inhibitors
TargetsProto-oncogene proteins c-akt
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNuclea Biotechnologies LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuclea Biotechnologies LLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A